|
emulsification |
9 |
|
neuroprotection |
9 |
|
silicone oil |
9 |
|
anti-inflammatory |
7 |
|
retina |
7 |
|
vitreoretinal surgery |
7 |
|
acute ocular hypertensive injury |
6 |
|
amphiphilic |
6 |
|
eye‐on‐a‐chip |
6 |
|
tamponade |
6 |
|
transcorneal electrical stimulation |
6 |
|
3d culturing |
5 |
|
fibroblasts |
5 |
|
high‐molecular‐weight additive |
5 |
|
myofibroblasts |
5 |
|
stromal fibrosis |
5 |
|
transforming growth factor-beta 1 |
5 |
|
corneal scarring |
4 |
|
coulter counter |
4 |
|
eye-on-a-chip |
4 |
|
fibroblast |
4 |
|
human keratocytes |
4 |
|
laser light scattering |
4 |
|
lycium barbarum polysaccharides |
4 |
|
tgfβ1 |
4 |
|
762 vitreoretinal surgery |
3 |
|
764 vitreous substitutes |
3 |
|
ahmed glaucoma valve |
3 |
|
animal models |
3 |
|
autoimmune diseases |
3 |
|
cell therapy |
3 |
|
ciliochoroidal detachment |
3 |
|
clinical practice |
3 |
|
collagen–alginate composite hydrogel |
3 |
|
cornea |
3 |
|
diabetes |
3 |
|
diagnosis |
3 |
|
diet supplementation |
3 |
|
dimethylpolysiloxanes - chemistry |
3 |
|
double emulsion |
3 |
|
doxycycline |
3 |
|
droplet microfluidics |
3 |
|
electroretinography |
3 |
|
emulsions |
3 |
|
encapsulated cell therapy |
3 |
|
encapsulation |
3 |
|
endotamponade |
3 |
|
epithelial wound healing |
3 |
|
epithelium |
3 |
|
experimental therapy |
3 |
|
experimental – laboratory |
3 |
|
eye |
3 |
|
eye movements |
3 |
|
gene mutation |
3 |
|
hek cells |
3 |
|
herpes simplex keratitis |
3 |
|
immune homeostasis |
3 |
|
immunity |
3 |
|
infectious keratitis |
3 |
|
intestinal microbiota |
3 |
|
intravitreal |
3 |
|
management |
3 |
|
models, anatomic |
3 |
|
ocular disease |
3 |
|
perfluorobutylpentane (f4h5) |
3 |
|
posterior chamber |
3 |
|
quantitative collection |
3 |
|
retinal detachment |
3 |
|
saccades - physiology |
3 |
|
silicone oils - chemistry |
3 |
|
single cell |
3 |
|
success rate |
3 |
|
sustained drug delivery |
3 |
|
therapy |
3 |
|
treatment surgery |
3 |
|
viscosity |
3 |
|
vision |
3 |
|
all-aqueous droplets |
2 |
|
all-aqueous system |
2 |
|
angiogenesis |
2 |
|
antibacterial |
2 |
|
aqueous two-phase system |
2 |
|
assembly |
2 |
|
bioactivity preservation |
2 |
|
biomimetic |
2 |
|
biomolecular assembly |
2 |
|
cell encapsulation |
2 |
|
core-shell microcapsules |
2 |
|
cornea-on-a-chip |
2 |
|
dextran |
2 |
|
electrospray |
2 |
|
heavy silicone oil |
2 |
|
interfaces |
2 |
|
microengineered |
2 |
|
microfluidics |
2 |
|
ophthalmic drugs |
2 |
|
ophthalmology |
2 |
|
osseointegration |
2 |
|
phase separation |
2 |
|
poly(ethylene glycol) (peg) |
2 |
|
polyetheretherketone |
2 |
|
vitreous body - surgery - complications - prevention |
2 |
|
w/w/w double emulsion |
2 |
|
acute pancreatitis |
1 |
|
acute primary angle closure |
1 |
|
adverse event |
1 |
|
all-aqueous microfluidics |
1 |
|
anterior chamber depth |
1 |
|
anti-inflammation |
1 |
|
antibacterial properties |
1 |
|
antibiofilm |
1 |
|
antibiotics-free |
1 |
|
aqueous misdirection |
1 |
|
aqueous-two phase system |
1 |
|
arpe-19 cell line |
1 |
|
bacterial keratitis |
1 |
|
bio-heterojunction |
1 |
|
bio-heterojunctions |
1 |
|
biomaterials |
1 |
|
cataract extraction |
1 |
|
cell death |
1 |
|
cell protection |
1 |
|
cell viability |
1 |
|
circumpapillary vessel density |
1 |
|
coating materials |
1 |
|
cutaneous regeneration |
1 |
|
cytotoxicity |
1 |
|
electrochemistry |
1 |
|
enzyme |
1 |
|
ex-press |
1 |
|
ferroptosis |
1 |
|
fibrous membranes |
1 |
|
filtering surgery |
1 |
|
glaucoma |
1 |
|
glucose-unlocked |
1 |
|
goniosynechialysis |
1 |
|
heterojunctions |
1 |
|
implant infection |
1 |
|
interfacial coacervation |
1 |
|
intraocular pressure |
1 |
|
liquid chromatography-mass spectrometry |
1 |
|
macular edema |
1 |
|
metabolic biomarkers |
1 |
|
metabolomics |
1 |
|
microfibers |
1 |
|
miniature drainage device |
1 |
|
mxene |
1 |
|
mxenes |
1 |
|
nanomaterials |
1 |
|
nanosheets |
1 |
|
ophthalmic endoscope |
1 |
|
optical coherence tomography angiography |
1 |
|
orthopedic implant |
1 |
|
orthopedic implants |
1 |
|
oxidation |
1 |
|
oxides |
1 |
|
peek |
1 |
|
peptides |
1 |
|
phacoemulsification |
1 |
|
phototherapy |
1 |
|
primary angle-closure glaucoma |
1 |
|
primary open-angle glaucoma |
1 |
|
probiotic |
1 |
|
reactive oxygen species (ros) |
1 |
|
ros scavenging |
1 |
|
self-tandem |
1 |
|
severe and end stage of glaucoma |
1 |
|
silicone tube |
1 |
|
spin-coating |
1 |
|
surface tension |
1 |
|
tamponade effect |
1 |
|
tissue regeneration |
1 |
|
trabeculectomy |
1 |
|
visual acuity |
1 |
|
vitrectomy |
1 |
|
wound healing |
1 |
